Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 82,645 | 83,561 | 65,359 | 69,194 | 70,869 |
| Cost of Goods | 60,720 | 59,145 | 46,589 | 46,602 | 50,485 |
| Gross Profit | 21,925 | 24,416 | 18,770 | 22,592 | 20,384 |
| Operating Expenses | 22,834 | 19,511 | 15,315 | 19,876 | 14,237 |
| Operating Income | -189 | 5,050 | 4,044 | 3,318 | 6,632 |
| Interest Expense | 330 | 1,547 | 195 | 233 | 213 |
| Other Income | -1,056 | -213 | -536 | 157 | -86 |
| Pre-tax Income | -1,575 | 3,290 | 3,313 | 3,242 | 6,333 |
| Income Tax | 319 | -23,547 | 1,387 | 173 | 1,214 |
| Net Income Continuous | -1,894 | 26,837 | 1,926 | 3,069 | 5,119 |
| Net Income | $-1,894 | $26,837 | $1,926 | $3,069 | $5,119 |
| EPS Basic Total Ops | -0.06 | 0.84 | 0.06 | 0.10 | 0.16 |
| EPS Basic Continuous Ops | -0.06 | 0.84 | 0.06 | 0.10 | 0.16 |
| EPS Diluted Total Ops | -0.06 | 0.82 | 0.06 | 0.09 | 0.16 |
| EPS Diluted Continuous Ops | -0.06 | 0.82 | 0.06 | 0.09 | 0.16 |
| EPS Diluted Before Non-Recurring Items | -9,999.00 | -9,999.00 | -9,999.00 | N/A | N/A |
| EBITDA(a) | $2,900 | $8,267 | $5,840 | $6,079 | $8,382 |